Travere Therapeutics, Inc. - Common Stock (NQ:TVTX)
41.08
+0.27
(+0.66%)
Streaming Delayed Price
Updated: 12:20 PM EDT, Apr 28, 2026
Add to My Watchlist
Price and Volume
Detailed Quote| Volume | 400,055 |
| Open | 40.97 |
| Bid (Size) | 41.04 (100) |
| Ask (Size) | 41.09 (100) |
| Prev. Close | 40.81 |
| Today's Range | 40.75 - 42.08 |
| 52wk Range | 13.88 - 43.31 |
| Shares Outstanding | 60,717,176 |
| Dividend Yield | N/A |
Top News
More News
Performance
More News
Read More
These stocks are moving in today's session ↗
April 14, 2026
Tuesday's session: gap up and gap down stocks ↗
April 14, 2026
Why Travere Therapeutics Stock Got Trounced on Tuesday ↗
January 13, 2026
Frequently Asked Questions
Is Travere Therapeutics, Inc. - Common Stock publicly traded?
Yes, Travere Therapeutics, Inc. - Common Stock is publicly traded.
What exchange does Travere Therapeutics, Inc. - Common Stock trade on?
Travere Therapeutics, Inc. - Common Stock trades on the Nasdaq Stock Market
What is the ticker symbol for Travere Therapeutics, Inc. - Common Stock?
The ticker symbol for Travere Therapeutics, Inc. - Common Stock is TVTX on the Nasdaq Stock Market
What is the current price of Travere Therapeutics, Inc. - Common Stock?
The current price of Travere Therapeutics, Inc. - Common Stock is 41.08
When was Travere Therapeutics, Inc. - Common Stock last traded?
The last trade of Travere Therapeutics, Inc. - Common Stock was at 04/28/26 12:20 PM ET
What is the market capitalization of Travere Therapeutics, Inc. - Common Stock?
The market capitalization of Travere Therapeutics, Inc. - Common Stock is 2.49B
How many shares of Travere Therapeutics, Inc. - Common Stock are outstanding?
Travere Therapeutics, Inc. - Common Stock has 2B shares outstanding.
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.